
Loading, please wait...

Loading, please wait...

Andhra Pradesh MedTech Zone (AMTZ) and Narayan Seva Sansthan (NSS) recently signed a transformative five-year agreement. This partnership focuses on creating affordable indigenous prosthetics to support millions of individuals with disabilities across India. By combining clinical expertise with advanced manufacturing, the initiative aims to make high-performance rehabilitation tech accessible to rural populations. Consequently, this collaboration aligns with NSS’s Vision 2030 to provide one lakh artificial limbs nationwide.
Currently, many advanced medical devices remain expensive because India relies heavily on imported components. For instance, a high-end above-knee prosthesis with pneumatic joints can cost approximately ₹41,000. However, the new partnership seeks to slash these prices significantly. Through backward integration, the organizations plan to produce these advanced limbs for just ₹10,000. Therefore, patients will receive quality care without the heavy financial burden typically associated with imported medical technology.
The collaboration extends far beyond standard artificial limbs. The two entities will develop myoelectric prosthetics, sports-specific limbs, and diabetic foot management solutions. Additionally, the project includes mobility aids like walkers, rollators, and advanced hearing aids. Because 69.5% of persons with disabilities live in rural areas, distribution camps will play a vital role. AMTZ will provide the R&D infrastructure while NSS leads the clinical validation and nationwide outreach efforts.
This initiative represents a significant step toward self-reliance in the healthcare sector. India has over 2.68 crore persons with disabilities, according to census data. By fostering local production, the agreement reduces the dependency on global supply chains. Furthermore, the organizations will jointly pursue patents and international funding to sustain long-term research. This strategic move ensures that high-performance assistive devices become a standard rather than a luxury for the Indian population.
Q1: What is the primary goal of the AMTZ and NSS partnership?
The partnership aims to co-develop and manufacture affordable, high-performance prosthetic and assistive devices within India, specifically targeting a reduction in costs for advanced artificial limbs.
Q2: How much will the advanced limbs cost under this initiative?
The collaboration aims to reduce the cost of advanced above-knee prostheses from the current ₹41,000 to approximately ₹10,000 through indigenous manufacturing.
Q3: Which types of devices are covered under this agreement?
The agreement covers myoelectric prosthetics, diabetic foot braces, mobility aids like wheelchairs and crutches, and advanced hearing aids.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AMTZ and Narayan Seva Sansthan partner to manufacture affordable indigenous prosthetics, aiming to reduce costs of advanced limbs from ₹41,000 to ₹10,000....
8 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today